Maastricht University Medical Center
4 clinical trials · 4 recruiting · OTHER
Trials by Maastricht University Medical Center
RECRUITINGNCT05655780
The Role of the Tumor Molecular Profile (CMS), UGT1A1 Genotype and Beta-glucuronidase Activity of the Intestinal...
Irinotecan-based systemic therapy is a treatment option for metastatic or unresectable colorectal cancer. However, this therapy has two major disadvantages, namely, an...
Sponsor: Maastricht University Medical CenterEnrolling: 1041 location
Colorectal Neoplasms
RECRUITINGNCT06582355
FMRI-neurofeedback in Parkinson's Disease
Rationale: Current treatment of patients with Parkinson's disease (PD) is mainly based on the modulation of neural activity in the motor circuits of the basal ganglia and cerebral...
Sponsor: Maastricht University Medical CenterEnrolling: 602 locations
Parkinson Disease
RECRUITINGNCT06676345
Mechanical Complications of Acute Myocardial Infarction: a Multicenter Prospective Study
In 2019, the international study titled "CAUTION Study - 1" (MeChanical complicAtions of acUte myocardial infarcTion: an InternatiOnal multiceNter cohort study), a retrospective...
Sponsor: Maastricht University Medical CenterEnrolling: 8001 location
Ventricular Septal DefectPapillary Muscle RuptureCardiac Rupture+1
RECRUITINGNCT02650453
Ongoing Registry of Deep Venous Reconstructions
Ongoing registration of deep venous obstructive disease patients treated by means of percutaneous transluminal angioplasty (PTA) and stenting with or without endophlebectomy...
Sponsor: Maastricht University Medical CenterEnrolling: 10001 location
Venous Thrombosis